A pharmacoepidemiological study of the consumption of antiparkinson drugs in the Basque Autonomous Community (Spain) (1992-2004).
OBJECTIVE
To monitor the rise in consumption of antiparkinson drugs as well as the prevalence of this illness in the Basque Autonomous Community (Spain) over a period of 13 years (1992-2004).


METHODS
A retrospective population-based study where consumption of antiparkinson drugs was conducted using data obtained from the ECOM (Especialidades Consumo de Medicamentos) database of the Spanish Ministry of Health, which contains the number of prescriptions filled in community pharmacies and charged to the National Health System. The results are expressed as DID, Defined daily doses per 1000 inhabitants per day.


CONCLUSIONS
Consumption of antiparkinson drugs has increased in the Basque Autonomous Community.
Osinaga
Eider Abasolo
EA
Preventive Medicine and Public Health Department of the Faculty of Pharmacy, Basque Country University, Paseo de la Universidad, 7. 01006 Vitoria-Gasteiz, Spain. eider.abasolo@ehu.es
Inchaurregui
Luis Carlos Abecia
LC
Ikobaltzeta
Itziar Etxeandia
IE
Alonso
Natalia Burgos
NB
Del Pozo
Javier García
JG
D014150:Antipsychotic Agents / Q000191:economics / Q000627:therapeutic use*; D019992:Databases as Topic; D017723:Drug Utilization Review / Q000191:economics / Q000706:statistics & numerical data*; D006801:Humans; D008137:Longitudinal Studies; D010300:Parkinson Disease / Q000188:drug therapy* / Q000453:epidemiology*; D012189:Retrospective Studies; D013030:Spain / Q000453:epidemiology
D014150:Antipsychotic Agents